Submitted by Jack Attack on
Jointly provided by: Results from several key clinical trials evaluating therapeutic approaches for patients with metastatic breast cancer, metastatic castration resistant prostate cancer and non-small cell lung cancer were presented at the European Society for Medical Oncology (ESMO) 2016 Congress on October 7–11, 2016 in Copenhagen, Denmark. Participate in any of the following activities and hear leading experts in their respective fields discuss the implications for current practice and future research.
|